Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
about
Epigenetic modulators as therapeutic targets in prostate cancerPotential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Combining Epigenetic and Immunotherapy to Combat Cancer.Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-Lymphocyte Responses in Patients with Myelodysplastic Syndrome.Epigenetic actions of environmental factors and promising drugs for cancer therapy.The Role of DNA Methylation in Cancer.Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?Targeting DNA Methyltranferases in Urological Tumors.
P2860
Q28071912-4C4C8CFC-40AC-412E-B6B6-1D40DB56CBFDQ33624680-DF133A89-D97C-4E49-B788-1312AE89B8E8Q36213219-85CC72E4-5447-4D74-B6D2-87A1CEF94915Q36407481-5C1C808D-F475-4D10-AA5E-B5445116A110Q37022306-E455FB9D-0768-4F5E-8E14-0EB8B00ABE50Q37391981-9B51E5C9-010C-4D09-B488-D84D4AB79678Q38730989-502D6DCF-41CA-4A43-A483-39FAE016307FQ38779204-96404321-527C-426C-9685-0C6AF1012F9DQ38854734-4781A8D3-EF15-4AF9-BB0F-953EB8D2E488Q47923445-F19C0294-60B7-4BA7-847F-05B2F55081ABQ49724675-64423BA2-EEE4-4452-9C55-2062E27F8A8FQ52966734-46CAD304-3561-4406-B37B-99863932A3BFQ53810338-37864BB2-8534-4B00-AF23-69F345E60B47Q55435258-1CDB9BCF-4751-4D74-9B38-B8210716A323
P2860
Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunomodulatory action of the ...... n cancer cells and xenografts.
@ast
Immunomodulatory action of the ...... n cancer cells and xenografts.
@en
type
label
Immunomodulatory action of the ...... n cancer cells and xenografts.
@ast
Immunomodulatory action of the ...... n cancer cells and xenografts.
@en
prefLabel
Immunomodulatory action of the ...... n cancer cells and xenografts.
@ast
Immunomodulatory action of the ...... n cancer cells and xenografts.
@en
P2093
P2860
P1433
P1476
Immunomodulatory action of the ...... n cancer cells and xenografts.
@en
P2093
Adam R Karpf
Benjamin E Paluch
Elizabeth A Griffiths
Golda Collamat-Lai
Junko Matsuzaki
Pietro Taverna
Pragya Srivastava
Smitha R James
P2860
P304
P356
10.1080/15592294.2015.1017198
P577
2015-01-01T00:00:00Z